Literature DB >> 6546466

Dynamic alterations in hippocampal morphology following intra-ventricular kainic acid.

J E Franck.   

Abstract

Several primary and secondary reactions were observed in rat hippocampus at various times following low doses of intraventricular kainic acid. The well documented fulminating lesion of subfield CA3a was evident, however, with the parameters of the present study, the acute neuronal death was restricted to areas which have been shown by others to have an exceptionally dense mossy fiber input. Neurons in subfields CA3c and CA4 also die, however, this was apparent only after a survival time of 2 weeks; prior to this, these cells went through a period of chromatolysis and dendritic swelling. In remaining subfields, principally 'CA2' and CA1, a third type of change was observed at longer intervals of 1 month. This was characterized by neuronal shrinkage and chromophilia and eventual cell loss. The present study provides additional observations on the actions of kainic acid in the hippocampus and may be relevant to the dynamic pathology of temporal lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546466     DOI: 10.1007/bf00691859

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  The incidence of Ammon's horn sclerosis.

Authors:  J A CORSELLIS
Journal:  Brain       Date:  1957-06       Impact factor: 13.501

2.  A modified cupric-silver technique for the impregnation of degenerating neurons and their processes.

Authors:  J Carlsen; J S De Olmos
Journal:  Brain Res       Date:  1981-03-16       Impact factor: 3.252

3.  Fink-Heimer silver impregnation of degenerating axons and terminals in mounted cryostat sections of fresh and fixed brains.

Authors:  A Hjorth-Simonsen
Journal:  Stain Technol       Date:  1970-09

4.  Mesial temporal (Ammon's horn) sclerosis as a common cause of epilepsy. Aetiology, treatment, and prevention.

Authors:  M A Falconer
Journal:  Lancet       Date:  1974-09-28       Impact factor: 79.321

5.  Loss and reacquisition of hippocampal synapses after selective destruction of CA3-CA4 afferents with kainic acid.

Authors:  J V Nadler; B W Perry; C Gentry; C W Cotman
Journal:  Brain Res       Date:  1980-06-09       Impact factor: 3.252

6.  Effects of anaesthetics and anticonvulsants on the action of kainic acid in the rat hippocampus.

Authors:  R Zaczek; M F Nelson; J T Coyle
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

7.  Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid.

Authors:  J V Nadler; B W Perry; C Gentry; C W Cotman
Journal:  J Comp Neurol       Date:  1980-07-15       Impact factor: 3.215

8.  The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid.

Authors:  Y Ben-Ari; E Tremblay; O P Ottersen; B S Meldrum
Journal:  Brain Res       Date:  1980-06-02       Impact factor: 3.252

9.  Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures.

Authors:  E A Cavalheiro; D A Riche; G Le Gal La Salle
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-06

10.  Selective chromatolysis of neurons in the gerbil brain: a possible consequence of "epileptic" activity produced by common carotid artery occlusion.

Authors:  A W Brown; D E Levy; M Kublik; J Harrow; F Plum; J B Brierley
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

View more
  2 in total

1.  Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus.

Authors:  Yun B Kim; Jae K Ryu; Hong J Lee; In J Lim; Dongsun Park; Min C Lee; Seung U Kim
Journal:  BMC Neurosci       Date:  2010-03-26       Impact factor: 3.288

2.  Distribution of ischemic neuronal damage in the dorsal hippocampus of rat.

Authors:  R Schmidt-Kastner; K A Hossmann
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.